Bangladesh on Thursday approved the emergency use of China's Sinopharm Covid-19 vaccine, two days after allowing Russia's Sputnik amidst concern over the availability of the
Oxford-AstraZeneca vaccine produced by the Serum Institute of India.
The development came as health officials reported 88 deaths in the country due to the coronavirus in one day, taking the total number of fatalities to 11,393.
Directorate General of Drug Administration Major General Mahbubur Rahman told reporters here that the Bangladesh government has issued the "emergency use approval for the Sinopharm vaccine".
